Altering microRNA miR15a/16 Levels as Potential Therapy in CLL: Extrapolating from the De Novo NZB Mouse Model

作者: Siddha Kasar , Yao Yuan , Chingiz Underbayev , Dan Vollenweider , Matt Hanlon

DOI: 10.5772/28685

关键词: BiologyBone marrowLifetime riskmicroRNAPeripheral bloodDiseaseImmunologyHematological malignancyLymphatic systemEtiology

摘要: … diseases, various cancers and a potential host of other diseases. For example, serum levels of miR-141 can be used to differentiate patients with prostate cancer from normal healthy …

参考文章(68)
S X Qian, W Xu, Y Zhu, H R Qiu, L J Chen, J Y Li, Y P Zhang, L M Duan, H Lu, Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization. Experimental Oncology. ,vol. 29, pp. 116- 120 ,(2007)
Martin M. Corcoran, Omid Rasool, Yie Liu, Arati Iyengar, Dan Grander, Rachel E. Ibbotson, Mats Merup, Xiushan Wu, Vadim Brodyansky, Anne C. Gardiner, Gunnar Juliusson, Robert M. Chapman, Ganka Ivanova, Mary Tiller, Gosta Gahrton, Nick Yankovsky, Eugene Zabarovsky, David G. Oscier, Stefan Einhorn, Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood. ,vol. 91, pp. 1382- 1390 ,(1998) , 10.1182/BLOOD.V91.4.1382
Hulya Yazici, Jennifer Zipprich, Tao Peng, Elif Z Akisik, Hulya Tigli, Mustafa Isin, Ebru E Akisik, Mary Beth Terry, Ruby T Senie, Lequn Li, Minhao Peng, Zhiming Liu, Nejat Dalay, Regina M Santella, None, Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups. Journal of Oncology. ,vol. 2009, pp. 827532- 827532 ,(2009) , 10.1155/2009/827532
G. van Haaften, R. Agami, Tumorigenicity of the miR-17-92 cluster distilled Genes & Development. ,vol. 24, pp. 1- 4 ,(2010) , 10.1101/GAD.1887110
Phong Trang, Jason F Wiggins, Christopher L Daige, Chris Cho, Michael Omotola, David Brown, Joanne B Weidhaas, Andreas G Bader, Frank J Slack, Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice Molecular Therapy. ,vol. 19, pp. 1116- 1122 ,(2011) , 10.1038/MT.2011.48
Emma Flordal Thelander, Koichi Ichimura, V. Peter Collins, Sarah H. Walsh, Gisela Barbany, Anette Hagberg, Anna Laurell, Richard Rosenquist, Catharina Larsson, Svetlana Lagercrantz, Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma Leukemia Research. ,vol. 31, pp. 1219- 1230 ,(2007) , 10.1016/J.LEUKRES.2006.10.022
E. Moussay, K. Wang, J.-H. Cho, K. van Moer, S. Pierson, J. Paggetti, P. V. Nazarov, V. Palissot, L. E. Hood, G. Berchem, D. J. Galas, MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 6573- 6578 ,(2011) , 10.1073/PNAS.1019557108
L. Naldini, U. Blomer, F. H. Gage, D. Trono, I. M. Verma, Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 11382- 11388 ,(1996) , 10.1073/PNAS.93.21.11382
S Nayak, R W Herzog, Progress and prospects: immune responses to viral vectors Gene Therapy. ,vol. 17, pp. 295- 304 ,(2010) , 10.1038/GT.2009.148